Overview

Long-term Study Of Ropinirole In Restless Legs Syndrome

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This is an initial placebo-controlled study followed by open treatment evaluating the effectiveness and tolerability of ropinirole long-term in patients with moderate to severe Restless Legs Syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole